feed,title,long_url,short_url
Benzinga,Roche's Faricimab On Par With Rival Regeneron's Aflibercept In Four Late-Stage Studies In Vision Loss Disorder,https://www.benzinga.com/general/biotech/21/02/19642201/roches-faricimab-on-par-with-rival-regenerons-aflibercept-in-four-late-stage-studies-in-vision-lo,https://j.mp/3aYKuip
